# Trial of rPA-102 Vaccine in Healthy Adult Volunteers

> **NCT00100724** · PHASE2 · COMPLETED · sponsor: **VaxGen** · enrollment: 480 (—)

## Conditions studied

- Anthrax

## Interventions

- **BIOLOGICAL:** rPA102

## Key facts

- **NCT ID:** NCT00100724
- **Lead sponsor:** VaxGen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 480 (—)
- **Last updated:** 2006-01-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100724, "Trial of rPA-102 Vaccine in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00100724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*